GlassScriptPhysician profile
Richard Seth Bloomfeld
NPI 1194700534
$26,812.37
in general payments reported to CMS, 2019-2025
10 companies · $465 in 2025
The $465 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $2,466 · 2021: $4,168 · 2022: $6,916 · 2023: $998 · 2024: $135 · 2025: $465.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $888 · Consulting Fee: $610 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $887.68 |
| Consulting Fee | $610.00 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $18,749.85 | 2019-2025 | Rinvoq, Skyrizi |
| Lilly USA, LLC | $6,461.21 | 2022 | |
| Fresenius Kabi USA, LLC | $610.00 | 2023 | Idacio |
| Janssen Biotech, INC. | $380.04 | 2021-2024 | Tremfya, Stelara |
| Pentax of America, INC. | $178.86 | 2025 | Pentax Medical, Inspira, C2 Cryoballoon Focal Controller |
| Takeda Pharmaceuticals U.S.A., INC. | $150.00 | 2022 | |
| Celgene Corporation | $116.95 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $90.91 | 2021 | |
| Cook Medical LLC | $74.55 | 2022-2025 | Hemospray |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Bloomfeld listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.